Alpha Tau Medical Ltd. (DRTS) stock, explained like you're 5

Is Alpha Tau Medical Ltd. a small, medium or large cap company?

No. Alpha Tau Medical Ltd. is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.3 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Alpha Tau Medical Ltd. makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves DRTS stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) (Alpha Tau Medical)
• DRTS Oct 2026 12.500 call (DRTS261016C00012500) Stock Historical Prices & Data (Yahoo! Finance Canada)
• Clinical Trial Progress Might Change The Case For Investing In Alpha Tau Medical (DRTS) (Simply Wall Street)
• Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5 1 plan (Stock Titan)
• This Small Cap Biotech Posted Impressive Brain Cancer Data But There’s A Catch (Stocktwits)

Key terms to know before you follow DRTS

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility